In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against the other Jim Cramer stocks with huge upside potential. During the episode of Mad Money aired on ...

ARM heads into earnings facing a more skeptical market after a volatile post-IPO run. Licensing strength and uptake of the Armv9 architecture are key to maintaining growth and margin expansion.

ARM Holdings ARM executives reassured investors that the company’s business model protects it from direct tariff impacts amid growing U.S.-China trade tensions, according to its fourth quarter ...

Arm Holdings reported a robust fiscal fourth quarter, with revenue rising 34% year-over-year to US$1.24 billion, driven by strong royalty contributions. The chip design firm posted a net income of ...

Arm didn't provide an outlook for fiscal 2026 due to economic uncertainty. End-market demand for smartphones could take a big hit, hurting Arm's royalty revenue. A sky-high valuation adds to the ...

Getty A woman has claimed that her best friend recently got “my full name” tattooed on her arm as a “birthday surprise” — and she’s not happy about it. The woman detailed her ...

External control arms (ECAs) - also known as synthetic control arms - are based on real world data (RWD) pulled from electronic health records, medical claims, wearable devices and other sources ...

Arm Holdings plc ARM will release earnings results for the third quarter, after the closing bell on Wednesday, May 7. Analysts expect the Cambridge, the UK-based company to report quarterly ...

Commissions do not affect our editors' opinions or evaluations. ARMs are home loans whose rates can vary over the life of the loan. Unlike a fixed-rate mortgage, which carries the same interest ...

Post-fight, Della Maddalena revealed he had suffered a gruesome broken arm in the first round against Burns. A picture of his X-ray, which showed his arm totally out of place, subsequently went ...

ATLANTA — This is why the Cincinnati Reds can't have nice things. Or even wild-card playoff spots. Not quite to the quarter-pole mark of the season, the early results for the Reds don't suggest ...

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations?